Acthrel

Acthrel is a brand name of corticorelin, approved by the FDA in the following formulation(s):

ACTHREL (corticorelin ovine triflutate - injectable; injection)

• 
  Manufacturer: FERRING
  
  Approval date: May 23, 1996
  
  Strength(s): EQ 0.1MG BASE/VIAL ^[RLD]

Has a generic version of Acthrel been approved?

No. There is currently no therapeutically equivalent version of Acthrel available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Acthrel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Acthrel.

See also...

• Acthrel Consumer Information (Cerner Multum)
• Corticorelin ovine triflutate Consumer Information (Cerner Multum)